Treffer: Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Title:
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study
Authors:
Ferriss, James S. a, Java, James J. b, Bookman, Michael A. c, Fleming, Gini F. d, Monk, Bradley J. e, Walker, Joan L. f, Homesley, Howard D. g, Fowler, Jeffrey h, Greer, Benjamin E. i, Boente, Matthew P. j, Burger, Robert A. k, ⁎
Source:
In Gynecologic Oncology October 2015 139(1):17-22
Database:
ScienceDirect